Amaç

JPharmTech aims to inform all pharmaceutical scientists about the latest and essential research on drug development.

JPharmTech’s primary and future goals are;

  • to have a strong international editorial and advisory board
  • to increase the recognition of the JPharmTech world-wide
  • to be one of the most-cited journals with a high impact factor

Kapsam

JPharmTech publishes three issues per year (April, August, and December) and primarily accepts original research and review articles covering the formulation, characterization and stability studies of drug delivery systems as well as the latest studies and scientific findings on the products already marketed.

JPharmTech accepts manuscripts from the following areas:

  • Conventional drug delivery systems
  • Novel drug delivery systems
  • Biopharmaceutics
  • Pharmacokinetics
  • Bioavailability & bioequivalence
  • Radiopharmaceuticals
  • Pharmaceutical technology
  • Pharmaceutical nano & biotechnology
  • Cosmetics & cosmeceutical products